Tirzepatide 60mg
Tirzepatide is a dual GIP and GLP-1 receptor agonist, making it structurally and pharmacologically distinct from single-incretin compounds. It is one of the most widely studied molecules in current metabolic research.
- Dual GIP / GLP-1 receptor agonist
- 39-amino-acid synthetic peptide with C20 fatty diacid moiety
- Extended half-life supports infrequent dosing schedules in study protocols
- Presentation
- 60 mg Pen
- Purity
- 99.59%
Sold strictly for in-vitro laboratory research. Not for human or veterinary consumption.
Research background
Tirzepatide was developed as a single molecule capable of engaging two incretin receptors simultaneously. Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) both influence insulin secretion, but they act through different receptor populations and different downstream signalling patterns.
The published literature has examined this twin-incretin approach across insulin secretion, glucagon suppression, gastric emptying rate, appetite signalling in the hypothalamus, and adipose tissue behaviour. Interest in the GIP arm specifically centres on whether it modifies energy handling in ways GLP-1 alone does not.
Handling and storage
Lyophilised material is stable for extended periods when kept sealed, dry, and away from light. Long-term storage in research settings is commonly at -20°C, with short transit at ambient temperature considered acceptable for lyophilised powders.
Once reconstituted, solutions are refrigerated at 2-8°C and used within a limited window, as peptides in aqueous solution degrade far faster than in powder form. Repeated freeze-thaw cycles are avoided.
Reconstitution notes
Peptides in this catalogue are supplied lyophilised. In laboratory settings they are typically reconstituted with bacteriostatic or sterile water added slowly down the inside wall of the vial, never injected directly onto the powder pellet.
The vial is then left to dissolve on its own, or swirled gently. Vigorous shaking is avoided because mechanical shear can denature peptide chains and reduce measurable potency in subsequent assays.
Purity and batch testing
Every batch we list is accompanied by third-party analytical testing. The Certificate of Analysis linked on this page shows the lot number, HPLC purity trace, and mass spectrometry identity confirmation for the exact batch held in stock.
Purity figures quoted on this page are taken directly from that report rather than from a manufacturer datasheet, so what you read here matches the vial that ships.
Frequently asked questions
- What is the difference between tirzepatide and a GLP-1-only peptide?
- Tirzepatide binds both the GIP and GLP-1 receptors, whereas semaglutide-class peptides act on GLP-1 alone. Research interest focuses on whether the added GIP activity changes insulin, glucagon and adipose responses.
- What concentration is the pen supplied at?
- This listing is a 60 mg presentation. Working concentration depends entirely on the volume of solvent used during reconstitution in the receiving laboratory.
- Is this product for human consumption?
- No. Everything in the Fox Peptides catalogue is supplied strictly for in-vitro laboratory research use. It is not a medicine and is not for human or veterinary consumption.
- Do you provide a Certificate of Analysis?
- Yes. Each batch is third-party tested and the Certificate of Analysis for the lot currently in stock is linked directly on this page, showing HPLC purity and mass spectrometry identity confirmation.
- Where do you ship and how long does delivery take?
- We ship across the UK with tracked delivery. Orders are dispatched from the UK once payment clears, so there are no customs delays for UK customers.
- How do I pay?
- Checkout uses secure open-banking bank transfer. You approve the payment inside your own banking app, and your order is confirmed automatically once the transfer clears.